Table 2. Potential Resources to Consider for Patient Use.
| Organization | Details of materials | Link |
|---|---|---|
| US Food and Drug Administration (FDA) | Regularly updated patient materials about the basics of biosimilars, FAQs, and PDF infographics. | https://www.fda.gov/drugs/biosimilars/patient-materials |
| Canadian Agency for Drugs and Technologies in Health (CADTH) | A concise tool about biosimilar basics for patients prescribed a biosimilar. The CADTH is an independent, not-for-profit organization. Patients can subscribe to a CADTH newsletter and follow CADTH on Twitter. | https://cadth.ca/sites/default/files/pdf/biosimilar_drugs_patient_en.pdf |
| American Pharmacists Association (APhA) | Biologics and biosimilar drug products: pharmacist guide to patients’ frequently asked questions. | https://www.pharmacist.com/Advocacy/Issues/Biosimilars/Biologics-and-Biosimilar-Drug-Products-Pharmacist-Guide-to-Patients-Frequently-Asked-Questions |
| Cancer Support Community | A website with patient information, a quick patient guide, and videos about why biosimilars are important. Includes a Cancer Support Community locater. | https://www.cancersupportcommunity.org/what-biosimilar |
| Susan G. Komen | Patient materials related to basic facts about biosimilars: includes various fact sheets, a video, and podcasts. | https://blog.komen.org/?s=biosimilar |
| American Cancer Society (ACS) Cancer Action Network | Public policy resources that provide patient information and videos on understanding biosimilars, and FAQs. | https://www.fightcancer.org/policy-resources/understanding-biologic-and-biosimilar-drugs |
| Cancer Care Ontario (CCO) | Biosimilar information that patients need to know (more specific to Canada) with an online format, video, and PDF handout with space for patients to make notes about questions they may have. | https://www.cancercareontario.ca/en/cancer-treatments/biologic-biosimilar-therapy/biosimilars |
| European Society for Medical Oncology (ESMO) Biosimilars Portal: Patient Resources | Predominantly EU-focused materials that address patient concerns regarding biosimilars. The materials include infographics, a video (in 8 languages), and questions and answers about biosimilars (in 23 languages). A link is also provided to US FDA patient materials. | https://www.esmo.org/policy/biosimilarsportal/patient-resource |
| Explanation of Benefits (EOB) information | A website that patients can use to help them decipher their explanation of benefits. | https://www.verywellhealth.com/understanding-your-eob-1738641 |
Note. EU = European Union; FAQs = frequently asked questions.